Sculptra® Therapy is the injection into the skin and underlying tissues of poly-L-lactic acid. Sculptra® therapy is designed to help correct skin depressions, such as creases, wrinkles, folds, scars, hallow eye rings, degenerative skin aging ad facial lipoatrophy (loss of fat).
Sculptra® is a poly-L-lactic acid implant in the form of a sterile apyrogenic suspension. Poly-L-lactic acid is a biocompatible (does not harm the body), biodegradable (broken down/metabolized by the body), synthetic polymer from the alpha-hydroxy-acid family (fruit acids). Poly-L-lactic acid has been used medically for
many years in dissolvable stitches, and does not require pre-treatment skin testing for allergies.
My physician has informed me that depending on the area and condition treated, the volume of Sculptra® used and the injection technique, the effect of a treatment with Sculptra® may last from 1 to 2 years, but that in some cases the duration of the effect may be shorter or longer. Most areas of treatment will require 2 to 4 sessions, usually at 3 to 6 week intervals, for optimal correction. Because the individual responses to Sculptra® therapy may vary, the exact number of treatment sessions required cannot be predicted with complete accuracy. Additionally, to maintain the desired degree of correction, intermittent “touch-up” treatments may be needed.
After each injection session, tissue volume in the treated area will gradually build up over the following weeks and months, as your body produces new collagen (neocollagenesis). At the time of your return visit for your next session of Sculptra® therapy, your response to the previous treatment will be assessed, and additional treatments can be performed if needed and agreed upon to optimize your correction. Sculptra® therapy does not treat or cure the underlying cause or disease of the tissue or fat loss; rather it is designed to improve the appearance of the affected area(s).
Some of the possible risks of Sculptra® therapy include:
- After the injection(s) some common injection-related reactions probably will occur, these may include
swelling, redness, pain, itching, discoloration and tenderness at the injection site. These typically resolve
spontaneously, usually within 1 to 15 days after injection.
- Because Sculptra® therapy injections are administered in a solution containing water, there will be an initial
swelling (edema) that will be noticeable for at least several hours, or perhaps several days. This effect is
temporary, and does not affect the long-term tissue response.
- Small bumps under the skin, termed micro-nodules, which may be non-visible to visible, may be felt in the
areas of treatment. Usually, these bumps may only be felt when pressing on the skin. Micro-nodules
typically last from 6 to 12 months, and may spontaneously disappear. They usually do not require treatment,
and usually do not have any symptoms.
- Induration, or a feeling of fullness or thickness, can be felt in the injection area. This is a normal response of
the treated tissue to the process of inflammation and neocollagenesis. Simply massaging the treated areas
gently 3 to 5 times per day for 3 to 5 minutes, for 3 to 5 days after the injection, can help minimize
induration.
- Visible bumps may occur in rare instances, and they may be associated with redness, tenderness, skin
discoloration or textural alteration. These bumps, which may be termed granulomas, may or may not require
treatment, including, but not limited to, injections, freezing or excision.
- Other rarely reported adverse events include: injection site abscess, allergic reaction, skin hypertrophy
and/or atrophy, malaise, fatigue, and edema.
- Sculptra® therapy is contraindicated (not allowed) in pregnancy or during breast feeding. If you believe you
may be pregnant or you are breastfeeding, please inform the provider prior to injection
- Sculptra® therapy has been approved by the United States Food and Drug Administration (FDA), for the
restoration and/or correction of facial fat loss (lipoatrophy) in period with HIV. Sculptra® therapy has not
been specifically approved by the FDA for aesthetic (cosmetic use). Sculptra® therapy (New-Fill®) has been performed since 1999 in more than 150,000 patients in more than 30 countries, principally for cosmetic use.